Sibelium exerts anti-migraine effects by remodeling the gut microbiota and regulating metabolic and immune pathways of the brain-gut axis
International Immunopharmacology · 2026-05 · 177 · 116486
DOI: 10.1016/j.intimp.2026.116486 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-05. Verfasst von Zhenxin Ren und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological Sciences and Technology, Yili Normal University, Yining, Xinjiang 835000, China; Xinjiang Key Laboratory of Lavender Conservati…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Migraine Disorders, Brain, Brain-Gut Axis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Guilin University of Electronic Technology Guangxi Key Laboratory of Automatic Detection Technology and Instruments, Yili Normal University.
Abstract (Originalsprache)
BACKGROUND/OBJECTIVES: Migraine is a highly disabling neurological disorder closely associated with the brain-gut axis. The mechanism of action of sibelium (flunarizine), a commonly used prophylactic medication, is unclear but may act through modulation of the gut microbiota. Based on the "brain-gut-microbiota axis" theory, the effects of sibelium on gut microbiota and the underlying mechanism for migraine prevention were investigated. METHODS: A nitroglycerin-induced migraine model was established in C57BL/6 J mice to comprehensively evaluate the effects of sibelium on migraine behavior, neuroinflammation, and gut microbiota. RESULTS: Sibelium significantly delayed migraine onset (31.5%, p < 0.01), shortened the duration of ear redness (53.4%), and reduced head-scratching frequency (59.4%) compared with vehicle only. At the molecular level, sibelium effectively reversed migraine-related neurotransmitter imbalances by reducing serum levels of CGRP, NO, and SP, increasing 5-HT concentration, and suppressing abnormal expression of c-Fos, CGRP, and IL-1β proteins in brain tissue. Based on the 16S rRNA sequencing analysis, sibelium improved gut microbiota diversity in model mice (Chao1 index increased by 17.9%), enriched beneficial genera (e.g., Lactobacillus and Bifidobacterium), and reduced the growth of the conditional pathogen Helicobacter by 85%. LEfSe analysis and correlation studies revealed that anti-inflammatory-related microbiota (e.g., Lachnospiraceae NK4A136 group) negatively correlated with pro-inflammatory factors (c-Fos, IL-1β; r = -0.68, p = 0.001), and Lactobacillus positively correlated with IL-1β (r = 0.78, p < 0.001) after sibelium intervention. Functional prediction indicated that sibelium restored amino acid metabolism and immune pathway activity. CONCLUSIONS: Sibelium prevents and attenuates migraines by modulating the microbiota-immune-neural network within the gut-brain axis, providing a novel theoretical foundation for clinical intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biological Sciences and Technology, Yili Normal University, Yining, Xinjiang 835000, China; Xinjiang Key Laboratory of Lavender Conservation and Utilization, Yining, Xinjiang 835000, China.
- College of Biological Sciences and Technology, Yili Normal University, Yining, Xinjiang 835000, China.
- College of Biological Sciences and Technology, Yili Normal University, Yining, Xinjiang 835000, China; Xinjiang Key Laboratory of Lavender Conservation and Utilization, Yining, Xinjiang 835000, China; Guilin Medical Uni…
Förderung
- Guilin University of Electronic Technology Guangxi Key Laboratory of Automatic Detection Technology and Instruments
- Yili Normal University
Zitieren
APA
Ren, Z., Hu, H., Shang, T., & Wu, Z. (2026). Sibelium exerts anti-migraine effects by remodeling the gut microbiota and regulating metabolic and immune pathways of the brain-gut axis. International Immunopharmacology, 177, 116486. https://doi.org/10.1016/j.intimp.2026.116486
Vancouver
Ren Z, Hu H, Shang T, Wu Z. Sibelium exerts anti-migraine effects by remodeling the gut microbiota and regulating metabolic and immune pathways of the brain-gut axis. International Immunopharmacology. 2026;177:116486. doi:10.1016/j.intimp.2026.116486
BibTeX
@article{Ren2026,
author = {Ren, Zhenxin and Hu, Hengcai and Shang, Tiancui and Wu, Zhiwei},
title = {Sibelium exerts anti-migraine effects by remodeling the gut microbiota and regulating metabolic and immune pathways of the brain-gut axis},
journal = {International Immunopharmacology},
year = {2026},
volume = {177},
pages = {116486},
doi = {10.1016/j.intimp.2026.116486}
}
EUVIMED